Literature DB >> 8501273

The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs.

T H Howell1, J P Fiorellini, P Blackburn, S J Projan, J de la Harpe, R C Williams.   

Abstract

The aim of this study was to evaluate the effect of nisin, an antimicrobial peptide, on the development of plaque and gingivitis in beagle dogs when compared with 0.12% chlorhexidine and a placebo. 16 female beagle dogs 1 year of age were brought to optimum gingival health by scaling, root planing and polishing. At the conclusion of the pretreatment phase, the dogs were divided into 4 groups for the application of the test agents and were placed on a plaque promoting diet of Purina Dog Chow softened with water. Test agents included 100 micrograms/ml nisin and 300 micrograms/ml nisin formulated in a vehicle containing 1 mM NaEDTA; negative control comprised of exactly the same formulation but omitting nisin; and 0.12% chlorhexidine as Peridex. Throughout the treatment period, formulations were applied 2x daily to premolar teeth in each quadrant for 1 min using a Monojet syringe. The development of plaque and gingivitis was monitored at 15, 27, 39, 53, 74 and 88 days during the treatment phase using standard measurements of gingival index, plaque index, stain index and bleeding to probing. Throughout the treatment phase, plaque accumulation increased in all groups, but the rate of plaque build-up was less in groups treated with either nisin or chlorhexidine formulations compared with the placebo treated group. The gingival index of dogs in all groups increased throughout the study period. However, from day 27 onward, the groups receiving nisin had lower gingival index scores than did the placebo group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501273     DOI: 10.1111/j.1600-051x.1993.tb00369.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  17 in total

1.  A rapid and accurate 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide colorimetric assay for quantification of bacteriocins with nisin as an example.

Authors:  Fang Wang; Li-ting Cao; Song-hua Hu
Journal:  J Zhejiang Univ Sci B       Date:  2007-08       Impact factor: 3.066

Review 2.  Applications of the bacteriocin, nisin.

Authors:  J Delves-Broughton; P Blackburn; R J Evans; J Hugenholtz
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

3.  Mutacin II, a bactericidal antibiotic from Streptococcus mutans.

Authors:  M L Chikindas; J Novák; A J Driessen; W N Konings; K M Schilling; P W Caufield
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

4.  Natural Antimicrobials ε-Poly-L-lysine and Nisin A for Control of Oral Microflora.

Authors:  Mohamed Badaoui Najjar; Dimitri Kashtanov; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2009-12       Impact factor: 4.609

5.  Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.

Authors:  Adam Pepperney; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

Review 6.  Biomedical applications of nisin.

Authors:  J M Shin; J W Gwak; P Kamarajan; J C Fenno; A H Rickard; Y L Kapila
Journal:  J Appl Microbiol       Date:  2016-02-12       Impact factor: 3.772

7.  Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.

Authors:  Des Field; Lisa Quigley; Paula M O'Connor; Mary C Rea; Karen Daly; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Microb Biotechnol       Date:  2010-07       Impact factor: 5.813

8.  Evaluation of Nisin and LL-37 Antimicrobial Peptides as Tool to Preserve Articular Cartilage Healing in a Septic Environment.

Authors:  Ziba Najmi; Ajay Kumar; Alessandro C Scalia; Andrea Cochis; Bojana Obradovic; Federico A Grassi; Massimiliano Leigheb; Meriem Lamghari; Iraida Loinaz; Raquel Gracia; Lia Rimondini
Journal:  Front Bioeng Biotechnol       Date:  2020-06-12

9.  Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells.

Authors:  Jae M Shin; Islam Ateia; Jefrey R Paulus; Hongrui Liu; J Christopher Fenno; Alexander H Rickard; Yvonne L Kapila
Journal:  Front Microbiol       Date:  2015-06-18       Impact factor: 5.640

10.  Biomedical applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b MTCC10770.

Authors:  Baljinder Kaur; Praveen P Balgir; Bharti Mittu; Balvir Kumar; Neena Garg
Journal:  Biomed Res Int       Date:  2013-07-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.